Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review

Background: The stage 1 Norwood procedure and its variants represent the first step of palliation for hypoplastic left heart syndrome. Although appropriate postoperative thromboprophylaxis is integral, significant variance remains across institutional practices. The purpose of this systematic review...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and Applied Thrombosis/Hemostasis 2017-11, Vol.23 (8), p.911-921
Hauptverfasser: Agarwal, Arnav, Firdouse, Mohammed, Brar, Nishaan, Yang, Andy, Lambiris, Panos, Chan, Anthony K., Mondal, Tapas K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 921
container_issue 8
container_start_page 911
container_title Clinical and Applied Thrombosis/Hemostasis
container_volume 23
creator Agarwal, Arnav
Firdouse, Mohammed
Brar, Nishaan
Yang, Andy
Lambiris, Panos
Chan, Anthony K.
Mondal, Tapas K.
description Background: The stage 1 Norwood procedure and its variants represent the first step of palliation for hypoplastic left heart syndrome. Although appropriate postoperative thromboprophylaxis is integral, significant variance remains across institutional practices. The purpose of this systematic review is to estimate the incidence of thrombosis and thromboembolism following the Norwood or modified Blalock-Taussig shunt procedure and examine current thromboprophylaxis regimens. Methods: Ovid MEDLINE and Embase were searched from January 2000 to June 2016 for primary studies explicitly reporting incidence of thrombosis, thromboembolism (strokes and pulmonary embolisms), or shunt occlusion in neonates, infants, and children undergoing the Norwood procedure or any variant. All-cause mortality was a secondary outcome of interest. Results: Of 887 identified articles, 15 cohort studies were deemed eligible, the majority including modified Blalock-Taussig shunt patients. Reported incidence of thrombosis ranged from 0% to 40%; thromboembolic events were rarely reported. Overall mortality ranged from 4.5% to 31.3% across studies. Although most studies involved the long-term acetylsalicylic acid use, thromboprophylaxis strategies varied across studies. Due to substantial variability in event rates, no correlation was identified with thrombotic complications. Discussion: Clinical practice guidelines recommend that patients receive intraoperative unfractionated heparin therapy and either aspirin or no antithrombotic therapy postoperatively. Our findings suggest a substantial risk of thrombosis and thromboembolism and demonstrate substantial variation in thromboprophylaxis practices. Conclusion: Although postoperative thromboprophylaxis seems optimal, it remains controversial whether the long-term aspirin use is most effective. Our findings highlight the lack of a gold-standard thromboprophylaxis strategy and emphasize the need for more consistency.
doi_str_mv 10.1177/1076029616679506
format Article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_1843913934</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1076029616679506</sage_id><sourcerecordid>1843913934</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-98bedd529bfb2f94ad0a44eb0ca9308dc3dbb9d9ea3cdea81ab4b151a5d2ed3f3</originalsourceid><addsrcrecordid>eNp1kUtP3DAUhS0EAgrds0KW2LBJ61fimB0aQYvEoyp0HflxA0GJPdgJI6T--Ho6A0hILKzr6_PdY8sHoQNKvlEq5XdKZEWYqmhVSVWSagPtUsXrgknGN_M-y8VS30FfUnokhKpKVdtoh8laKiHJLvp74W3nwFvA2jt8pb2-hwH8iEOL7x5iGEwYO_tfXLeQV5-PZmGY56rHLviEz0Pfh0Xn7_H4APg6xEUIDv-KwYKbIpzgU3z7kkYY9NLuNzx3sNhHW63uE3xd1z305_zsbvazuLz5cTE7vSysIHIsVG3AuZIp0xrWKqEd0UKAIVYrTmpnuTNGOQWaWwe6ptoIQ0uqS8fA8ZbvoeOV7zyGpwnS2AxdstD32kOYUkNrwRXliouMHn1AH8MUfX5dw7gQ-QOZKDNFVpSNIaUIbTOP3aDjS0NJs0ym-ZhMHjlcG09mAPc28BpFBooVkHIC77d-avgP2ymYSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344196245</pqid></control><display><type>article</type><title>Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review</title><source>Sage Journals GOLD Open Access 2024</source><creator>Agarwal, Arnav ; Firdouse, Mohammed ; Brar, Nishaan ; Yang, Andy ; Lambiris, Panos ; Chan, Anthony K. ; Mondal, Tapas K.</creator><creatorcontrib>Agarwal, Arnav ; Firdouse, Mohammed ; Brar, Nishaan ; Yang, Andy ; Lambiris, Panos ; Chan, Anthony K. ; Mondal, Tapas K.</creatorcontrib><description>Background: The stage 1 Norwood procedure and its variants represent the first step of palliation for hypoplastic left heart syndrome. Although appropriate postoperative thromboprophylaxis is integral, significant variance remains across institutional practices. The purpose of this systematic review is to estimate the incidence of thrombosis and thromboembolism following the Norwood or modified Blalock-Taussig shunt procedure and examine current thromboprophylaxis regimens. Methods: Ovid MEDLINE and Embase were searched from January 2000 to June 2016 for primary studies explicitly reporting incidence of thrombosis, thromboembolism (strokes and pulmonary embolisms), or shunt occlusion in neonates, infants, and children undergoing the Norwood procedure or any variant. All-cause mortality was a secondary outcome of interest. Results: Of 887 identified articles, 15 cohort studies were deemed eligible, the majority including modified Blalock-Taussig shunt patients. Reported incidence of thrombosis ranged from 0% to 40%; thromboembolic events were rarely reported. Overall mortality ranged from 4.5% to 31.3% across studies. Although most studies involved the long-term acetylsalicylic acid use, thromboprophylaxis strategies varied across studies. Due to substantial variability in event rates, no correlation was identified with thrombotic complications. Discussion: Clinical practice guidelines recommend that patients receive intraoperative unfractionated heparin therapy and either aspirin or no antithrombotic therapy postoperatively. Our findings suggest a substantial risk of thrombosis and thromboembolism and demonstrate substantial variation in thromboprophylaxis practices. Conclusion: Although postoperative thromboprophylaxis seems optimal, it remains controversial whether the long-term aspirin use is most effective. Our findings highlight the lack of a gold-standard thromboprophylaxis strategy and emphasize the need for more consistency.</description><identifier>ISSN: 1076-0296</identifier><identifier>EISSN: 1938-2723</identifier><identifier>DOI: 10.1177/1076029616679506</identifier><identifier>PMID: 27879470</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Health risk assessment ; Humans ; Incidence ; Norwood Procedures - adverse effects ; Postoperative Complications - epidemiology ; Postoperative Complications - prevention &amp; control ; Systematic review ; Thromboembolism ; Thromboembolism - epidemiology ; Thromboembolism - etiology ; Thromboembolism - prevention &amp; control ; Thrombosis ; Thrombosis - epidemiology ; Thrombosis - etiology ; Thrombosis - prevention &amp; control</subject><ispartof>Clinical and Applied Thrombosis/Hemostasis, 2017-11, Vol.23 (8), p.911-921</ispartof><rights>The Author(s) 2016</rights><rights>The Author(s) 2016. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-98bedd529bfb2f94ad0a44eb0ca9308dc3dbb9d9ea3cdea81ab4b151a5d2ed3f3</citedby><cites>FETCH-LOGICAL-c407t-98bedd529bfb2f94ad0a44eb0ca9308dc3dbb9d9ea3cdea81ab4b151a5d2ed3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1076029616679506$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1076029616679506$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>313,314,780,784,792,21966,27853,27922,27924,27925,44945,45333</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1076029616679506?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27879470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Agarwal, Arnav</creatorcontrib><creatorcontrib>Firdouse, Mohammed</creatorcontrib><creatorcontrib>Brar, Nishaan</creatorcontrib><creatorcontrib>Yang, Andy</creatorcontrib><creatorcontrib>Lambiris, Panos</creatorcontrib><creatorcontrib>Chan, Anthony K.</creatorcontrib><creatorcontrib>Mondal, Tapas K.</creatorcontrib><title>Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review</title><title>Clinical and Applied Thrombosis/Hemostasis</title><addtitle>Clin Appl Thromb Hemost</addtitle><description>Background: The stage 1 Norwood procedure and its variants represent the first step of palliation for hypoplastic left heart syndrome. Although appropriate postoperative thromboprophylaxis is integral, significant variance remains across institutional practices. The purpose of this systematic review is to estimate the incidence of thrombosis and thromboembolism following the Norwood or modified Blalock-Taussig shunt procedure and examine current thromboprophylaxis regimens. Methods: Ovid MEDLINE and Embase were searched from January 2000 to June 2016 for primary studies explicitly reporting incidence of thrombosis, thromboembolism (strokes and pulmonary embolisms), or shunt occlusion in neonates, infants, and children undergoing the Norwood procedure or any variant. All-cause mortality was a secondary outcome of interest. Results: Of 887 identified articles, 15 cohort studies were deemed eligible, the majority including modified Blalock-Taussig shunt patients. Reported incidence of thrombosis ranged from 0% to 40%; thromboembolic events were rarely reported. Overall mortality ranged from 4.5% to 31.3% across studies. Although most studies involved the long-term acetylsalicylic acid use, thromboprophylaxis strategies varied across studies. Due to substantial variability in event rates, no correlation was identified with thrombotic complications. Discussion: Clinical practice guidelines recommend that patients receive intraoperative unfractionated heparin therapy and either aspirin or no antithrombotic therapy postoperatively. Our findings suggest a substantial risk of thrombosis and thromboembolism and demonstrate substantial variation in thromboprophylaxis practices. Conclusion: Although postoperative thromboprophylaxis seems optimal, it remains controversial whether the long-term aspirin use is most effective. Our findings highlight the lack of a gold-standard thromboprophylaxis strategy and emphasize the need for more consistency.</description><subject>Health risk assessment</subject><subject>Humans</subject><subject>Incidence</subject><subject>Norwood Procedures - adverse effects</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - prevention &amp; control</subject><subject>Systematic review</subject><subject>Thromboembolism</subject><subject>Thromboembolism - epidemiology</subject><subject>Thromboembolism - etiology</subject><subject>Thromboembolism - prevention &amp; control</subject><subject>Thrombosis</subject><subject>Thrombosis - epidemiology</subject><subject>Thrombosis - etiology</subject><subject>Thrombosis - prevention &amp; control</subject><issn>1076-0296</issn><issn>1938-2723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kUtP3DAUhS0EAgrds0KW2LBJ61fimB0aQYvEoyp0HflxA0GJPdgJI6T--Ho6A0hILKzr6_PdY8sHoQNKvlEq5XdKZEWYqmhVSVWSagPtUsXrgknGN_M-y8VS30FfUnokhKpKVdtoh8laKiHJLvp74W3nwFvA2jt8pb2-hwH8iEOL7x5iGEwYO_tfXLeQV5-PZmGY56rHLviEz0Pfh0Xn7_H4APg6xEUIDv-KwYKbIpzgU3z7kkYY9NLuNzx3sNhHW63uE3xd1z305_zsbvazuLz5cTE7vSysIHIsVG3AuZIp0xrWKqEd0UKAIVYrTmpnuTNGOQWaWwe6ptoIQ0uqS8fA8ZbvoeOV7zyGpwnS2AxdstD32kOYUkNrwRXliouMHn1AH8MUfX5dw7gQ-QOZKDNFVpSNIaUIbTOP3aDjS0NJs0ym-ZhMHjlcG09mAPc28BpFBooVkHIC77d-avgP2ymYSA</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Agarwal, Arnav</creator><creator>Firdouse, Mohammed</creator><creator>Brar, Nishaan</creator><creator>Yang, Andy</creator><creator>Lambiris, Panos</creator><creator>Chan, Anthony K.</creator><creator>Mondal, Tapas K.</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201711</creationdate><title>Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review</title><author>Agarwal, Arnav ; Firdouse, Mohammed ; Brar, Nishaan ; Yang, Andy ; Lambiris, Panos ; Chan, Anthony K. ; Mondal, Tapas K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-98bedd529bfb2f94ad0a44eb0ca9308dc3dbb9d9ea3cdea81ab4b151a5d2ed3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Health risk assessment</topic><topic>Humans</topic><topic>Incidence</topic><topic>Norwood Procedures - adverse effects</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - prevention &amp; control</topic><topic>Systematic review</topic><topic>Thromboembolism</topic><topic>Thromboembolism - epidemiology</topic><topic>Thromboembolism - etiology</topic><topic>Thromboembolism - prevention &amp; control</topic><topic>Thrombosis</topic><topic>Thrombosis - epidemiology</topic><topic>Thrombosis - etiology</topic><topic>Thrombosis - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agarwal, Arnav</creatorcontrib><creatorcontrib>Firdouse, Mohammed</creatorcontrib><creatorcontrib>Brar, Nishaan</creatorcontrib><creatorcontrib>Yang, Andy</creatorcontrib><creatorcontrib>Lambiris, Panos</creatorcontrib><creatorcontrib>Chan, Anthony K.</creatorcontrib><creatorcontrib>Mondal, Tapas K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and Applied Thrombosis/Hemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Agarwal, Arnav</au><au>Firdouse, Mohammed</au><au>Brar, Nishaan</au><au>Yang, Andy</au><au>Lambiris, Panos</au><au>Chan, Anthony K.</au><au>Mondal, Tapas K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review</atitle><jtitle>Clinical and Applied Thrombosis/Hemostasis</jtitle><addtitle>Clin Appl Thromb Hemost</addtitle><date>2017-11</date><risdate>2017</risdate><volume>23</volume><issue>8</issue><spage>911</spage><epage>921</epage><pages>911-921</pages><issn>1076-0296</issn><eissn>1938-2723</eissn><abstract>Background: The stage 1 Norwood procedure and its variants represent the first step of palliation for hypoplastic left heart syndrome. Although appropriate postoperative thromboprophylaxis is integral, significant variance remains across institutional practices. The purpose of this systematic review is to estimate the incidence of thrombosis and thromboembolism following the Norwood or modified Blalock-Taussig shunt procedure and examine current thromboprophylaxis regimens. Methods: Ovid MEDLINE and Embase were searched from January 2000 to June 2016 for primary studies explicitly reporting incidence of thrombosis, thromboembolism (strokes and pulmonary embolisms), or shunt occlusion in neonates, infants, and children undergoing the Norwood procedure or any variant. All-cause mortality was a secondary outcome of interest. Results: Of 887 identified articles, 15 cohort studies were deemed eligible, the majority including modified Blalock-Taussig shunt patients. Reported incidence of thrombosis ranged from 0% to 40%; thromboembolic events were rarely reported. Overall mortality ranged from 4.5% to 31.3% across studies. Although most studies involved the long-term acetylsalicylic acid use, thromboprophylaxis strategies varied across studies. Due to substantial variability in event rates, no correlation was identified with thrombotic complications. Discussion: Clinical practice guidelines recommend that patients receive intraoperative unfractionated heparin therapy and either aspirin or no antithrombotic therapy postoperatively. Our findings suggest a substantial risk of thrombosis and thromboembolism and demonstrate substantial variation in thromboprophylaxis practices. Conclusion: Although postoperative thromboprophylaxis seems optimal, it remains controversial whether the long-term aspirin use is most effective. Our findings highlight the lack of a gold-standard thromboprophylaxis strategy and emphasize the need for more consistency.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>27879470</pmid><doi>10.1177/1076029616679506</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1076-0296
ispartof Clinical and Applied Thrombosis/Hemostasis, 2017-11, Vol.23 (8), p.911-921
issn 1076-0296
1938-2723
language eng
recordid cdi_proquest_miscellaneous_1843913934
source Sage Journals GOLD Open Access 2024
subjects Health risk assessment
Humans
Incidence
Norwood Procedures - adverse effects
Postoperative Complications - epidemiology
Postoperative Complications - prevention & control
Systematic review
Thromboembolism
Thromboembolism - epidemiology
Thromboembolism - etiology
Thromboembolism - prevention & control
Thrombosis
Thrombosis - epidemiology
Thrombosis - etiology
Thrombosis - prevention & control
title Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T09%3A37%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20Management%20of%20Thrombotic%20and%20Thromboembolic%20Complications%20Following%20the%20Norwood%20Procedure:%20A%20Systematic%20Review&rft.jtitle=Clinical%20and%20Applied%20Thrombosis/Hemostasis&rft.au=Agarwal,%20Arnav&rft.date=2017-11&rft.volume=23&rft.issue=8&rft.spage=911&rft.epage=921&rft.pages=911-921&rft.issn=1076-0296&rft.eissn=1938-2723&rft_id=info:doi/10.1177/1076029616679506&rft_dat=%3Cproquest_AFRWT%3E1843913934%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2344196245&rft_id=info:pmid/27879470&rft_sage_id=10.1177_1076029616679506&rfr_iscdi=true